4//SEC Filing
Binder-Scholl Gwendolyn Knowlton 4
Accession 0001104659-18-054853
CIK 0001621227other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 8:02 PM ET
Size
5.6 KB
Accession
0001104659-18-054853
Insider Transaction Report
Form 4
Binder-Scholl Gwendolyn Knowlton
EVP, Adaptimmune LLC
Transactions
- Sale
American Depositary Shares
2018-08-29$10.25/sh−25,000$256,250→ 0 total
Footnotes (2)
- [F1]Each American Depositary Share ("ADS") represents six ordinary shares, nominal value GBP 0.001 per ordinary share, of the Issuer. The ordinary shares were obtained from the exercise of share options granted on March 20, 2015. The exercise of share options and the sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 29, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These ADSs were sold in multiple transactions at prices ranging from $10.15 to $10.41, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the ADSs sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001662116
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 8:02 PM ET
- Size
- 5.6 KB